Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-05 @ 12:47 AM
Study NCT ID:
NCT06429904
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-05-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nimotuzumab Plus NALIRIFOX in Locally Advanced Pancreatic Cancer
Sponsor:
Peking Union Medical College Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IST-Nim-PC-29
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None